{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T01:20:50Z","timestamp":1758417650545,"version":"3.44.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2008,3,1]],"date-time":"2008-03-01T00:00:00Z","timestamp":1204329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,3,1]],"date-time":"2008-03-01T00:00:00Z","timestamp":1204329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2008,3,1]],"date-time":"2008-03-01T00:00:00Z","timestamp":1204329600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2008,3,1]],"date-time":"2008-03-01T00:00:00Z","timestamp":1204329600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2008,3,1]],"date-time":"2008-03-01T00:00:00Z","timestamp":1204329600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2008,3,1]],"date-time":"2008-03-01T00:00:00Z","timestamp":1204329600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2008,3,1]],"date-time":"2008-03-01T00:00:00Z","timestamp":1204329600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004043","name":"Kanazawa Medical University","doi-asserted-by":"publisher","award":["S2006-1"],"award-info":[{"award-number":["S2006-1"]}],"id":[{"id":"10.13039\/501100004043","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2008,3]]},"DOI":"10.1016\/j.jns.2007.08.022","type":"journal-article","created":{"date-parts":[[2007,9,20]],"date-time":"2007-09-20T07:21:03Z","timestamp":1190272863000},"page":"13-19","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Increased frequency of CD4+T cells expressing fractalkine receptor CX3CR1 in patients with HTLV-1 associated myelopathy\/tropical spastic paraparesis (HAM\/TSP), but its AIDS susceptible polymorphisms are not associated with the disease"],"prefix":"10.1016","volume":"266","author":[{"given":"Mineki","family":"Saito","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichiro","family":"Usuku","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimiyoshi","family":"Arimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuji","family":"Izumo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuhiro","family":"Osame","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiro","family":"Ohara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2007.08.022_bib1","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0140-6736(85)92734-5","article-title":"Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis","volume":"2","author":"Gessain","year":"1985","journal-title":"Lancet"},{"key":"10.1016\/j.jns.2007.08.022_bib2","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/S0140-6736(86)91298-5","article-title":"HTLV-I associated myelopathy, a new clinical entity","volume":"1","author":"Osame","year":"1986","journal-title":"Lancet"},{"key":"10.1016\/j.jns.2007.08.022_bib3","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3109\/13550289609146899","article-title":"Therapeutic trials in 200 patients with HTLV-I-associated myelopathy\/tropical spastic paraparesis","volume":"2","author":"Nakagawa","year":"1996","journal-title":"J Neurovirol"},{"key":"10.1016\/j.jns.2007.08.022_bib4","first-page":"1096","article-title":"The risk of development of HTLV-I-associated myelopathy\/tropical spastic paraparesis among persons infected with HTLV-I","volume":"3","author":"Kaplan","year":"1990","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.jns.2007.08.022_bib5","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1046\/j.1440-1789.2000.00320.x","article-title":"HTLV-I-associated myelopathy","volume":"20Suppl","author":"Izumo","year":"2000","journal-title":"Neuropathology"},{"key":"10.1016\/j.jns.2007.08.022_bib6","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1080\/13550280260422668","article-title":"Pathological mechanisms of human T-cell lymphotropic virus type I-associated myelopathy (HAM\/TSP)","volume":"8","author":"Osame","year":"2002","journal-title":"J Neurovirol"},{"key":"10.1016\/j.jns.2007.08.022_bib7","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1172\/JCI11517","article-title":"Fractalkine (CX3CL1) as an amplification circuit of polarized Th1 responses","volume":"107","author":"Fraticelli","year":"2001","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jns.2007.08.022_bib8","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1161\/01.ATV.0000095360.62479.1F","article-title":"Fractalkine in vascular biology: from basic research to clinical disease","volume":"24","author":"Umehara","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jns.2007.08.022_bib9","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0092-8674(00)80438-9","article-title":"Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion","volume":"91","author":"Imai","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.jns.2007.08.022_bib10","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1084\/jem.188.8.1413","article-title":"Fractalkine and CX3CR1 mediate a novel mechanism of leukocyte capture, firm adhesion, and activation under physiologic flow","volume":"188","author":"Fong","year":"1998","journal-title":"J Exp Med"},{"key":"10.1016\/j.jns.2007.08.022_bib11","doi-asserted-by":"crossref","first-page":"6173","DOI":"10.4049\/jimmunol.168.12.6173","article-title":"Dual functions of fractalkine\/CX3C ligand 1 in trafficking of perforin+\/granzyme B+cytotoxic effector lymphocytes that are defined by CX3CR1 expression","volume":"168","author":"Nishimura","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.jns.2007.08.022_bib12","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1126\/science.287.5461.2274","article-title":"Rapid progression to AIDS in HIV+ individuals with a structural variant of the chemokine receptor CX3CR1","volume":"287","author":"Faure","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.jns.2007.08.022_bib13","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/ana.410400114","article-title":"Human T-lymphotropic virus type I-associated myelopathy and tax gene expression in CD4+T lymphocytes","volume":"40","author":"Moritoyo","year":"1996","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jns.2007.08.022_bib14","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1097\/00005072-199307000-00010","article-title":"Immunocytochemical analysis of the cellular infiltrate in the spinal cord lesions in HTLV-I-associated myelopathy","volume":"52","author":"Umehara","year":"1993","journal-title":"J Neuropathol Exp Neurol"},{"year":"1990","series-title":"Review of WHO Kagoshima meeting and diagnostic guidelines for HAM\/TSP","author":"Osame","key":"10.1016\/j.jns.2007.08.022_bib15"},{"key":"10.1016\/j.jns.2007.08.022_bib16","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1182\/blood.V97.7.1925","article-title":"Polymorphism in the fractalkine receptor CX3CR1 as a genetic risk factor for coronary artery disease","volume":"97","author":"Moatti","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.jns.2007.08.022_bib17","doi-asserted-by":"crossref","first-page":"586","DOI":"10.3109\/13550289809114225","article-title":"Analysis of HTLV-I proviral load in 202 HAM\/TSP patients and 243 asymptomatic HTLV-I carriers: high proviral load strongly predisposes to HAM\/TSP","volume":"4","author":"Nagai","year":"1998","journal-title":"J Neurovirol"},{"key":"10.1016\/j.jns.2007.08.022_bib18","doi-asserted-by":"crossref","first-page":"3220","DOI":"10.1128\/jvi.63.8.3220-3226.1989","article-title":"Activation of endogenous c-fos proto-oncogene expression by human T-cell leukemia virus type I-encoded p40tax protein in the human T-cell line, Jurkat","volume":"63","author":"Nagata","year":"1989","journal-title":"J Virol"},{"key":"10.1016\/j.jns.2007.08.022_bib19","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1349-7006.1990.tb02554.x","article-title":"Heterogeneity of antigen molecules recognized by anti-tax1 monoclonal antibody Lt-4 in cell lines bearing human T cell leukemia virus type I and related retroviruses","volume":"81","author":"Tanaka","year":"1990","journal-title":"Jpn J Cancer Res"},{"key":"10.1016\/j.jns.2007.08.022_bib20","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1182\/blood.V95.4.1386.004k22_1386_1392","article-title":"Abundant tax protein expression in CD4+T cells infected with human T-cell lymphotropic virus type I (HTLV-I) is prevented by cytotoxic T lymphocytes","volume":"95","author":"Hanon","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.jns.2007.08.022_bib21","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.neulet.2004.10.042","article-title":"T280M and V249I polymorphisms of fractalkine receptor CX3CR1 and ischemic cerebrovascular disease","volume":"374","author":"Hattori","year":"2005","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.jns.2007.08.022_bib22","doi-asserted-by":"crossref","first-page":"5121","DOI":"10.4049\/jimmunol.173.8.5121","article-title":"The role of CTL in persistent viral infection: cytolytic gene expression in CD8+lymphocytes distinguishes between individuals with a high or low proviral load of human T cell lymphotropic virus type 1","volume":"173","author":"Vine","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.jns.2007.08.022_bib23","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1007\/s00251-006-0082-9","article-title":"Immunostimulation by induced expression of NKG2D and its MIC ligands in HTLV-1-associated neurologic disease","volume":"58","author":"Azimi","year":"2006","journal-title":"Immunogenetics"},{"key":"10.1016\/j.jns.2007.08.022_bib24","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1126\/science.285.5428.727","article-title":"Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA","volume":"285","author":"Bauer","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.jns.2007.08.022_bib25","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1086\/424598","article-title":"Persistent paradox of natural history of human T lymphotropic virus type I: parallel analyses of Japanese and Jamaican carriers","volume":"190","author":"Hisada","year":"2004","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jns.2007.08.022_bib26","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1099\/vir.0.80509-0","article-title":"Differences in viral and host genetic risk factors for development of human T-cell lymphotropic virus type 1 (HTLV-1)-associated myelopathy\/tropical spastic paraparesis between Iranian and Japanese HTLV-1-infected individuals","volume":"86","author":"Sabouri","year":"2005","journal-title":"J Gen Virol"},{"key":"10.1016\/j.jns.2007.08.022_bib27","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s004010050435","article-title":"Expression of adhesion molecules and monocyte chemoattractant protein-1 (MCP-1) in the spinal cord lesions in HTLV-I-associated myelopathy","volume":"91","author":"Umehara","year":"1996","journal-title":"Acta Neuropathol (Berl)"},{"key":"10.1016\/j.jns.2007.08.022_bib28","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.1002\/art.10622","article-title":"Migration of CX3CR1-positive T cells producing type 1 cytokines and cytotoxic molecules into the synovium of patients with rheumatoid arthritis","volume":"46","author":"Nanki","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jns.2007.08.022_bib29","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0022-510X(99)00232-4","article-title":"Th1 dominance in HAM\/TSP and the optico-spinal form of multiple sclerosis versus Th2 dominance in mite antigen-specific IgE myelitis","volume":"172","author":"Horiuchi","year":"2000","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.jns.2007.08.022_bib30","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S0022-510X(00)00322-1","article-title":"Flow cytometric differentiation of Asian and Western types of multiple sclerosis, HTLV-1-associated myelopathy\/tropical spastic paraparesis (HAM\/TSP) and hyperIgEaemic myelitis by analyses of memory CD4 positive T cell subsets and NK cell subsets","volume":"177","author":"Wu","year":"2000","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.jns.2007.08.022_bib31","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0165-5728(01)00393-9","article-title":"Tc1\/Tc2 and Th1\/Th2 balance in Asian and Western types of multiple sclerosis, HTLV-I-associated myelopathy\/tropical spastic paraparesis and hyperIgEaemic myelitis","volume":"119","author":"Ochi","year":"2001","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.jns.2007.08.022_bib32","doi-asserted-by":"crossref","first-page":"3335","DOI":"10.1182\/blood.V99.9.3335","article-title":"High frequencies of Th1-type CD4(+) T cells specific to HTLV-1 Env and Tax proteins in patients with HTLV-1-associated myelopathy\/tropical spastic paraparesis","volume":"99","author":"Goon","year":"2002","journal-title":"Blood"}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X0700576X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X0700576X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T15:38:19Z","timestamp":1758382699000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X0700576X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3]]},"references-count":32,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2008,3]]}},"alternative-id":["S0022510X0700576X"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2007.08.022","relation":{},"ISSN":["0022-510X"],"issn-type":[{"type":"print","value":"0022-510X"}],"subject":[],"published":{"date-parts":[[2008,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increased frequency of CD4+T cells expressing fractalkine receptor CX3CR1 in patients with HTLV-1 associated myelopathy\/tropical spastic paraparesis (HAM\/TSP), but its AIDS susceptible polymorphisms are not associated with the disease","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2007.08.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}